<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosgen</journal-id>
<journal-title-group>
<journal-title>PLOS Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7390</issn>
<issn pub-type="epub">1553-7404</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pgen.1006041</article-id>
<article-id pub-id-type="publisher-id">PGENETICS-D-16-00303</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Post-translational modification</subject><subj-group><subject>Phosphorylation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Signal transduction</subject><subj-group><subject>Cell signaling</subject><subj-group><subject>TOR signaling</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Fungi</subject><subj-group><subject>Yeast</subject><subj-group><subject>Schizosaccharomyces</subject><subj-group><subject>Schizosaccharomyces pombe</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Model organisms</subject><subj-group><subject>Yeast and fungal models</subject><subj-group><subject>Schizosaccharomyces pombe</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular structures and organelles</subject><subj-group><subject>Golgi apparatus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cell processes</subject><subj-group><subject>Secretory pathway</subject><subj-group><subject>Golgi apparatus</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular structures and organelles</subject><subj-group><subject>Vacuoles</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Signal transduction</subject><subj-group><subject>Cell signaling</subject><subj-group><subject>Signaling cascades</subject><subj-group><subject>Stress signaling cascade</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular structures and organelles</subject><subj-group><subject>Lysosomes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Amino acids</subject><subj-group><subject>Aliphatic amino acids</subject><subj-group><subject>Leucine</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic chemistry</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Amino acids</subject><subj-group><subject>Aliphatic amino acids</subject><subj-group><subject>Leucine</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Amino acids</subject><subj-group><subject>Aliphatic amino acids</subject><subj-group><subject>Leucine</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Fission Yeast SCYL1/2 Homologue Ppk32: A Novel Regulator of TOR Signalling That Governs Survival during Brefeldin A Induced Stress to Protein Trafficking</article-title>
<alt-title alt-title-type="running-head">TORC1 Inhibition Promotes Survival upon BFA Induced Stress</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2349-7534</contrib-id>
<name name-style="western">
<surname>Kowalczyk</surname>
<given-names>Katarzyna M.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Petersen</surname>
<given-names>Janni</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University, Adelaide, Australia</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>South Australia Health and Medical Research Institute, Adelaide, Australia</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Copenhaver</surname>
<given-names>Gregory P.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>The University of North Carolina at Chapel Hill, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: KMK JP. Performed the experiments: KMK JP. Analyzed the data: KMK JP. Wrote the paper: KMK JP.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">janni.petersen@flinders.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>5</month>
<year>2016</year>
</pub-date>
<volume>12</volume>
<issue>5</issue>
<elocation-id>e1006041</elocation-id>
<history>
<date date-type="received">
<day>8</day>
<month>2</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>4</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Kowalczyk, Petersen</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pgen.1006041"/>
<abstract>
<p>Target of Rapamycin (TOR) signalling allows eukaryotic cells to adjust cell growth in response to changes in their nutritional and environmental context. The two distinct TOR complexes (TORC1/2) localise to the cell’s internal membrane compartments; the endoplasmic reticulum (ER), Golgi apparatus and lysosomes/vacuoles. Here, we show that Ppk32, a SCYL family pseudo-kinase, is a novel regulator of TOR signalling. The absence of <italic>ppk32</italic> expression confers resistance to TOR inhibition. Ppk32 inhibition of TORC1 is critical for cell survival following Brefeldin A (BFA) induced stress. Treatment of wild type cells with either the TORC1 specific inhibitor rapamycin or the general TOR inhibitor Torin1 confirmed that a reduction in TORC1 activity promoted recovery from BFA induced stress. Phosphorylation of Ppk32 on two residues that are conserved within the SCYL pseudo-kinase family are required for this TOR inhibition. Phosphorylation on these sites controls Ppk32 protein levels and sensitivity to BFA. BFA induced ER stress does not account for the response to BFA that we report here, however BFA is also known to induce Golgi stress and impair traffic to lysosomes. In summary, Ppk32 reduce TOR signalling in response to BFA induced stress to support cell survival.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author Summary</title>
<p>The Target of Rapamycin (TOR) pathway plays a central role coordinating cell growth and cell division in response to the different cellular environments. This is achieved by TOR controlling various metabolic processes, cell growth and cell division, and in part by the localisation of TOR protein complexes to specific internal endomembranes and compartments. Here, we report a novel role for the SCYL family pseudo-kinase, Ppk32 in restraining TOR signalling when cells experience stresses, which specifically affect endomembranes and compartments where TOR complexes are localised. Cells exposed to endomembrane stress (induced by Brefeldin A), displayed increased cell survival when simultaneously treated with the TOR complex 1 (TORC1) inhibitor, rapamycin, presumably because the reduction in TORC1 signalling slows cellular processes to allow cells sufficient time to recover and adapt to this stress. Importantly cancer, neuro-degeneration and neurological diseases are all associated with stress to the endomembrane protein trafficking system. Our findings suggest that therapeutic rapamycin treatment to reduce TOR signalling and block proliferation of cancer cells, which are inherently experiencing such stress, may have the unintended consequence of enhancing cell survival. It is notable, therefore, that our reported mechanisms to reduce Ppk32 protein levels, likely to be conserved in humans, may represent a way to increase TOR signalling and thus increase cell death of cancer types with inherent stress to these internal membrane systems.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000289</institution-id>
<institution>Cancer Research UK</institution>
</institution-wrap>
</funding-source>
<award-id>C10888/A11178</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Petersen</surname>
<given-names>Janni</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000289</institution-id>
<institution>Cancer Research UK</institution>
</institution-wrap>
</funding-source>
<award-id>C10888/A9015</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Petersen</surname>
<given-names>Janni</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution>Flinders University - Adelaide, South Australia</institution>
</funding-source>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000770</institution-id>
<institution>University of Manchester</institution>
</institution-wrap>
</funding-source>
</award-group>
<funding-statement>This work was supported by Cancer Research UK [C10888/A9015], [grant number C10888/A11178] to JP and by Flinders and Manchester Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="7"/>
<table-count count="1"/>
<page-count count="21"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>TOR signalling allows eukaryotic cells to adapt their metabolism, cell growth, stress and survival to meet the demands of the prevailing conditions [<xref ref-type="bibr" rid="pgen.1006041.ref001">1</xref>]. TOR kinases form at least two distinct complexes: TOR complex 1 (TORC1) and TORC2 [<xref ref-type="bibr" rid="pgen.1006041.ref002">2</xref>–<xref ref-type="bibr" rid="pgen.1006041.ref004">4</xref>]. These complexes are defined by the presence of unique binding partners; Raptor interacts with TOR kinase in complex 1, whereas Rictor replaces Raptor in complex 2 [<xref ref-type="bibr" rid="pgen.1006041.ref002">2</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref004">4</xref>]. The yeasts differ from higher eukaryotes in having two separately encoded TOR kinases. In fission yeast Tor1 is the main kinase that binds Ste20 (rictor) in TORC2, whereas Tor2 is in a complex with Mip1 (raptor) in TORC1 [<xref ref-type="bibr" rid="pgen.1006041.ref005">5</xref>–<xref ref-type="bibr" rid="pgen.1006041.ref007">7</xref>]. Yeast and mammalian TORC1 responds to changes in the abundance of nutrients and growth factors (mammals) to adjust the cell cycle, cell growth and metabolism accordingly. The roles for TORC2 include modulation of the actin cytoskeleton [<xref ref-type="bibr" rid="pgen.1006041.ref003">3</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref008">8</xref>], stress responses [<xref ref-type="bibr" rid="pgen.1006041.ref009">9</xref>] and chaperone-mediated autophagy [<xref ref-type="bibr" rid="pgen.1006041.ref010">10</xref>]. Both TOR complexes localise to membrane-enclosed structures. In nutrient rich conditions, TORC1 is found on lysosomes [<xref ref-type="bibr" rid="pgen.1006041.ref011">11</xref>] and the Golgi apparatus [<xref ref-type="bibr" rid="pgen.1006041.ref012">12</xref>], whereas TORC2 localises mainly to the endoplasmic reticulum (ER) [<xref ref-type="bibr" rid="pgen.1006041.ref013">13</xref>]. TORC2 can also be found on the plasma membrane [<xref ref-type="bibr" rid="pgen.1006041.ref013">13</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref014">14</xref>] and lysosomes [<xref ref-type="bibr" rid="pgen.1006041.ref010">10</xref>].</p>
<p>The endoplasmic reticulum originates from the nuclear envelope to extend throughout the cell. ER membranes are in constant contact with the Golgi apparatus. COP-mediated trafficking, regulates vesicle transport both to and from the ER and Golgi and between Golgi stacks [<xref ref-type="bibr" rid="pgen.1006041.ref015">15</xref>]. Once proteins reach the trans-Golgi apparatus, they are directed either to plasma membrane, lysosomes or other vesicle-based compartments. Therefore, these endomembranes function as protein and lipid factories but also as scaffolds for complexes such as TOR signalling modules.</p>
<p>The lactone antibiotic Brefeldin A (BFA) inhibits the GEFs for class II ARFs (ADP-Ribosylation Factor a GTPase) [<xref ref-type="bibr" rid="pgen.1006041.ref016">16</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref017">17</xref>] to release ARF into the cytosol. This release reversibly blocks traffic between the Golgi and ER and within the Golgi stacks to generate Golgi stress. The BFA induced block to protein traffic can also induce ER stress through the unfolded protein response (UPR) [<xref ref-type="bibr" rid="pgen.1006041.ref018">18</xref>]. Furthermore, BFA impairs traffic to the lysosomes [<xref ref-type="bibr" rid="pgen.1006041.ref019">19</xref>]. Importantly, BFA has been key to elucidating the mechanisms of trafficking at the Golgi.</p>
<p>Here we report that Ppk32, a SCYL family pseudo-kinase, is a novel regulator of TOR signalling. Reduced TORC1 activity promoted survival upon Brefeldin A (BFA) induced stress. Ppk32 was critical for inhibition of TORC1 signalling and survival during this BFA induced stress. Ppk32 also controlled TORC1 activity during sexual differentiation and ablation of <italic>ppk32</italic><sup><italic>+</italic></sup> expression advanced differentiation. The response to BFA that we report here is not regulated though UPR induced ER stress. Therefore, cells are likely to sense Golgi stress, or impaired traffic to lysosomes, following BFA treatment. Finally we show that Ppk32 phosphorylation on two sites is important for function because it controls Ppk32 protein levels and determines cellular sensitivity to BFA induced stress and TOR inhibition. This target sites for phosphorylation are conserved through to human members of the SCYL pseudo-kinase family</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>The fission yeast SCYL homologue Ppk32 regulates TOR signalling</title>
<p>The ability of rapamycin to specifically inhibit TORC1 has facilitated extensive characterisation of TORC1; in contrast TORC2 regulation is less well defined. Preliminary data suggested that the <italic>S</italic>. <italic>pombe</italic> Ppk32 kinase co-immuno-precipitated with Tor1 (the main catalytic component of TORC2) in a large-scale screen to identify TORC2 interacting proteins. Small-scale Tor1 immuno-precipitations validated this interaction with Tor1, through co-precipitation of both Ppk32 and of PK tagged Ppk32 with Tor1 (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1A</xref>). Ppk32 is a member of the SCYL pseudo-kinase family that includes the human SCYL1 and SCYL2 kinases. SCYL kinases have an amino-terminal pseudo-kinase domain and carboxy-terminal serine-rich sequences separated by HEAT repeats that are known to facilitate protein-protein interactions. TOR kinases interact with Raptor (TORC1) and Rictor (TORC2). Interestingly, this interaction is mediated, in part, through the HEAT repeats found in all 3 proteins [<xref ref-type="bibr" rid="pgen.1006041.ref002">2</xref>]. Fission yeast TORC1 is localized to the surface of vacuoles (yeast lysosomes) and to undefined cytoplasmic foci that are not vacuoles [<xref ref-type="bibr" rid="pgen.1006041.ref020">20</xref>]. In contrast, TORC2 localises to cell ends and to the cell equator (sites of the ER and plasma membrane) during late stages of cell division [<xref ref-type="bibr" rid="pgen.1006041.ref021">21</xref>]. A GFP-Ppk32 strain (<xref ref-type="supplementary-material" rid="pgen.1006041.s001">S1B Fig</xref>) revealed that Ppk32 was present in the cytoplasm (although signals were faint), and it was excluded from the inside of vacuoles (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1B</xref>). In some places cytoplasmic Ppk32 accumulated in small foci (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1B-2</xref>), between two to ten foci were seen in each cell. Ppk32 was also concentrated at the cell equator during cell division in more than 60% of cells (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1B</xref>). Thus, Ppk32 localizes to structures where TORC1 and/or TORC2 may reside.</p>
<fig id="pgen.1006041.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006041.g001</object-id>
<label>Fig 1</label>
<caption>
<title>The fission yeast SCYL homologue Ppk32 regulates TOR signalling.</title>
<p>(A) Tor1 immuno-precipitations. Soluble proteins were extracted from exponentially grown strains: <italic>ppk32</italic>.<italic>PK</italic> strain (upper) and wild-type, <italic>ppk32</italic>.<italic>Δ</italic> and <italic>tor1 Δ</italic> (lower). Tor1 immuno-precipites and Ppk32 co-immuno-precipites were assessed from the same gels. The relative levels of specific Ppk32 immuno-precipitation are shown. (B) Live cell imaging: GFP and transmitted light images of GFP-Ppk32 and wild type control strains. (1) shows a projection of 4 single planes covering 0.5 nm (2) shows a single plane image, → indicates cytoplasmic foci. For <italic>wild type</italic> cells full Z-stack projection is shown (C, D) Growth assay. Exponentially YES-grown cells of indicated strains were spotted in 10-fold serial dilution onto rich medium plates (YES) or YES supplemented with Torin1, BFA or vehicle (DMSO) alone. (E,F) Early exponential cells grown in indicated media. Samples from un-perturbed cultures were subjected to Western blot analysis to monitor Ppk32 levels (E), * indicates a background band, or Maf1.PK (upper part) or Ser546 Gad8 phosphorylation (Lower part) (F). Ponceau S staining was used as a loading control.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.g001" xlink:type="simple"/>
</fig>
<p>In human cells the SCYL1 kinase has been implicated in retrograde traffic between the Golgi and ER [<xref ref-type="bibr" rid="pgen.1006041.ref022">22</xref>], a process that is affected by the lactone antibiotic Brefeldin A (BFA). BFA effectively blocks Golgi transport to compromise viability in fission yeast [<xref ref-type="bibr" rid="pgen.1006041.ref023">23</xref>]. The fission yeast genome encodes an additional SCYL homologue, Ppk3. Strains from which the genes encoding both homologues had been deleted were more sensitive to BFA than wild type controls (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1C</xref>) (and GFP-Ppk32 cells <xref ref-type="supplementary-material" rid="pgen.1006041.s001">S1C Fig</xref>). Importantly, Ppk32 but not Ppk3 deficient mutants were resistant to a potent inhibitor of both TOR complexes, Torin1 [<xref ref-type="bibr" rid="pgen.1006041.ref024">24</xref>] (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1C</xref>). This Ppk32 dependent resistance to Torin1 was determined by the nutritional context, as <italic>ppk32</italic>.<italic>Δ</italic> (<italic>ppk32</italic><sup>+</sup> deletion) cells were only resistant to Torin1 when they were also auxotrophic for leucine and grown on nutrient rich (YES) media (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1D</xref>). Neither prototrophic <italic>ppk32</italic>.<italic>Δ</italic> grown on rich YES nor auxotrophic <italic>ppk32</italic>.<italic>Δ</italic> mutants grown on minimal media were drug resistant. Therefore, unless otherwise stated, all experiments in this report use leucine autotrophic strains grown on rich YES medium.</p>
<p>Assessment of Ppk32 levels in total protein extracts revealed that Ppk32 protein levels in rich media were twice those of cells grown in minimal EMMG media (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1E</xref>). A similar increase of Ppk32.PK total protein levels was seen in YES grown cells (<xref ref-type="supplementary-material" rid="pgen.1006041.s001">S1E Fig</xref>). Addition of the Phos-tag reagent [<xref ref-type="bibr" rid="pgen.1006041.ref025">25</xref>] to the resolving gel revealed that Ppk32.PK is phosphorylated, however similar relative levels of phosphorylation were observed in both media (<xref ref-type="supplementary-material" rid="pgen.1006041.s001">S1E Fig</xref>). The increased Ppk32 total protein level in YES may explain the increased Torin1 resistance of <italic>ppk32</italic>.<italic>Δ</italic> cells compared to <italic>ppk32</italic><sup><italic>+</italic></sup> cells when grown in rich YES medium. Elevated TOR signalling or deficient drug uptake by <italic>ppk32</italic>.<italic>Δ</italic> mutant could account for the resistance to Torin1. The decline in TORC1 controlled Maf1 phosphorylation [<xref ref-type="bibr" rid="pgen.1006041.ref026">26</xref>] after Torin1 treatment followed similar dosage effects, in <italic>wt</italic> and <italic>ppk32</italic>.<italic>Δ</italic> cells (<xref ref-type="supplementary-material" rid="pgen.1006041.s001">S1D Fig</xref>) to indicate that <italic>ppk32</italic>.<italic>Δ</italic> mutants are proficient for drug uptake. Fission yeast TORC2 phosphorylates the AGC kinase Gad8 (AKT homolog) at Ser-456 [<xref ref-type="bibr" rid="pgen.1006041.ref027">27</xref>]. The phosphorylation profiles of two TOR substrates, Maf1 and Gad8.S546 phosphorylation (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1F</xref>), suggests that, while <italic>ppk32</italic>.<italic>Δ</italic> mutants cells are resistant to Torin1 (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1C</xref>), Ppk32 does not appear to have a major impact on either TORC1 or TORC2 signalling under non-stressed condition.</p>
</sec>
<sec id="sec004">
<title>TOR signalling controls Ppk32 levels</title>
<p>To gain further insight into TOR and Ppk32 regulation, Ppk32 protein levels were assessed in TOR deficient mutants. Tor2 is the main catalytic kinase component of TORC1 [<xref ref-type="bibr" rid="pgen.1006041.ref005">5</xref>–<xref ref-type="bibr" rid="pgen.1006041.ref007">7</xref>]. TORC1 is essential for growth of all organisms, including fission yeast, [<xref ref-type="bibr" rid="pgen.1006041.ref028">28</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref029">29</xref>]. We therefore incubated temperature sensitive <italic>tor2</italic>.<italic>51</italic> [<xref ref-type="bibr" rid="pgen.1006041.ref005">5</xref>] mutants at 37°C to inactivate TORC1 activity. Ppk32 levels were maintained at 37°C (the restrictive temperature) when TORC1 was inactivated (<xref ref-type="fig" rid="pgen.1006041.g002">Fig 2A</xref>). In contrast, Ppk32 levels in wild type cells were significantly reduced 2 hours following a shift to 37°C in wild type cells (<xref ref-type="fig" rid="pgen.1006041.g002">Fig 2A</xref>) (note: the level of an unknown protein, recognised by anti-ppk32 antibodies in <italic>ppk32</italic>.<italic>Δ</italic> mutants, is strongly induced by heat stress). In a similar heat stress experiment of wild type cells, TORC1 dependent Maf1 phosphorylation increased 1 hour upon after shift to 37°C (<xref ref-type="supplementary-material" rid="pgen.1006041.s002">S2A Fig</xref>), suggesting that TORC1 may increase 1 hr after heat stress (<xref ref-type="supplementary-material" rid="pgen.1006041.s002">S2A Fig</xref>). These results suggest that Ppk32 protein turnover requires TORC1 activity. Steady state Ppk32 proteins levels were reduced in strains that were TORC2 deficient because they lacked Ste20 (the fission yeast version of the conserved TORC2 specific component Rictor) (<xref ref-type="fig" rid="pgen.1006041.g002">Fig 2B</xref>), a similar decrease in Ppk32.PK total protein levels was seen in the <italic>ste20</italic>.<italic>Δ</italic> mutant (<xref ref-type="supplementary-material" rid="pgen.1006041.s002">S2C Fig</xref>). No significant reduction in Ppk32 levels was observed in <italic>tor1</italic>.<italic>Δ</italic> mutants, that lack the main TORC2 kinase, however Tor2 kinase can also interact with Ste20 and this interaction is enhanced in the absence of Tor1 [<xref ref-type="bibr" rid="pgen.1006041.ref030">30</xref>]. Simultaneous inhibition of both TORC1 and TORC2 through treatment with Torin1 did not significantly change Ppk32 levels (<xref ref-type="fig" rid="pgen.1006041.g002">Fig 2C</xref>). In summary, TORC1 negatively regulates Ppk32 protein levels whilst TORC2 is required to maintain steady state levels.</p>
<fig id="pgen.1006041.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006041.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Ppk32 protein level is regulated by TOR signalling.</title>
<p>All strains are leucine autotrophs. (A, B, C) Western blot analyses of Ppk32, * indicates a background band. Early exponential cells were grown in rich medium (YES). Samples from indicated cultures were subjected to Western blot. (A) Cells were shifted from 25°C to 37°C for indicated time. Note an unknown background band is unregulated by the heat stress. (C) Torin1 was added. Ponceau S staining was used as a loading control. (D) Growth assay. Exponentially grown cells of the indicated strains were spotted in 10-fold serial dilution onto rich medium plates (YES).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec005">
<title>Enhanced fitness of TORC1 and TORC2 mutants following deletion of <italic>ppk32</italic><sup><italic>+</italic></sup></title>
<p>The resistance to Torin1 induced TOR inhibition in Ppk32 deficient mutant cells suggests that Ppk32 opposes TOR signalling (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1C</xref>). Furthermore, TORC1 inhibition in <italic>tor2</italic>.<italic>51</italic> mutants, enhanced Ppk32 levels when compared to wild type cells (<xref ref-type="fig" rid="pgen.1006041.g002">Fig 2A</xref>). We therefore used colony size as a good proxy for cell fitness [<xref ref-type="bibr" rid="pgen.1006041.ref031">31</xref>] to ask whether Ppk32 contributes to the reduced growth rate fitness of <italic>tor2</italic>.<italic>51</italic> cells. Ppk32 removal enhanced <italic>tor2</italic>.<italic>51</italic> fitness (Figs <xref ref-type="fig" rid="pgen.1006041.g002">2D</xref> and <xref ref-type="fig" rid="pgen.1006041.g004">4A</xref>). Loss of <italic>ppk32</italic> also had a less pronounced, positive, impact on the fitness of <italic>tor1</italic>.<italic>Δ</italic> cells (Figs <xref ref-type="fig" rid="pgen.1006041.g002">2D</xref> and <xref ref-type="fig" rid="pgen.1006041.g004">4C</xref>). Thus, Ppk32 reduces the fitness of cells compromised for either TORC1 or TORC2 activity. Ppk32 may therefore constitute a novel inhibitor of TOR signalling. To test this possibility <italic>ppk32</italic><sup>+</sup> was overexpressed in wild type cells grown in minimal media to facilitate high levels of expression. Ppk32 over-expression dramatically reduced cell growth (<xref ref-type="supplementary-material" rid="pgen.1006041.s003">S3A Fig</xref>) and this block to cell proliferation correlated with a decrease in the TORC1 and TORC2 dependent Maf1.PK and Gad8 S546 phosphorylation respectively (<xref ref-type="supplementary-material" rid="pgen.1006041.s003">S3B Fig</xref>). In summary, elevation of Ppk32 levels reduced both TORC1 and TORC2 signalling, while abolition of <italic>ppk32</italic> expression provided Torin1 resistance and stimulated growth of TORC1 and TORC2 mutants.</p>
</sec>
<sec id="sec006">
<title>Decreased TORC1 signalling promotes survival during BFA induced stress</title>
<p>Brefeldin A (BFA) inhibits Guanine nucleotide Exchange Factors (GEFs) for ARF GTPases [<xref ref-type="bibr" rid="pgen.1006041.ref016">16</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref017">17</xref>]. ARFs regulate COPI recruitment to Golgi membranes to facilitate retrograde trafficking within the Golgi and from the Golgi to the ER [<xref ref-type="bibr" rid="pgen.1006041.ref032">32</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref033">33</xref>]. Importantly BFA can also induce ER stress through the unfolded protein response (UPR) and impair traffic to lysosomes [<xref ref-type="bibr" rid="pgen.1006041.ref019">19</xref>]. We next determined whether the BFA sensitivity of fission yeast observed here (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1C</xref>) arose from ER stress. In fission yeast UPR is regulated by Ire1 also known as Ppk4 [<xref ref-type="bibr" rid="pgen.1006041.ref034">34</xref>]. The <italic>ire1</italic>.<italic>Δ</italic> mutant was not sensitive to BFA whereas double <italic>ppk32</italic>.<italic>Δ ire1</italic>.<italic>Δ</italic> deletion mutant was (<xref ref-type="supplementary-material" rid="pgen.1006041.s004">S4A Fig</xref>). This result shows that the BFA sensitivity we observe arises from either Golgi stress or impaired traffic to lysosomes (yeast vacuoles). Interestingly, the human Ppk32 homolog the SCYL1 kinase has been implicated in retrograde traffic between the Golgi and ER [<xref ref-type="bibr" rid="pgen.1006041.ref022">22</xref>]. SCYL1 is thought to act as a scaffold protein that recruits ARFs to COPI complexes, furthermore, BFA treatment releases ARFs from Golgi membranes in to the cytosol [<xref ref-type="bibr" rid="pgen.1006041.ref035">35</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref036">36</xref>]</p>
<p>We next assessed the impact of BFA on TOR signalling in wild type and Ppk32 deficient cells. Previous work established that BFA treatment reduced mTORC1 activity [<xref ref-type="bibr" rid="pgen.1006041.ref037">37</xref>]. In wild type fission yeast cells both TORC1 and TORC2 activity were reduced by BFA treatment (<xref ref-type="fig" rid="pgen.1006041.g003">Fig 3A and 3B</xref>). Importantly, in <italic>ppk32</italic>.<italic>Δ</italic> mutants, the BFA induced TOR inhibition of both complexes was less pronounced to suggest that the BFA sensitivity of <italic>ppk32</italic>.<italic>Δ</italic> mutants (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1C</xref>) might arise from increased TOR activity in this mutant. To test this hypothesis, we generated a <italic>ppk32</italic>.<italic>Δ tor2</italic>.<italic>51</italic> double mutant in which TORC1 signalling would be reduced by the mutation in Tor2. The <italic>ppk32</italic>.<italic>Δ tor2</italic>.<italic>51</italic> double mutant was less sensitive to BFA than the single <italic>ppk32</italic>.<italic>Δ</italic> mutant alone (<xref ref-type="fig" rid="pgen.1006041.g004">Fig 4A</xref>) to imply that reduced TORC1 signalling may promote survival upon exposure to BFA induced stress [<xref ref-type="bibr" rid="pgen.1006041.ref026">26</xref>]. To further test this hypothesis rapamycin was added to BFA treated cells. Importantly although rapamycin treatment does reduce TORC1 activity (<xref ref-type="supplementary-material" rid="pgen.1006041.s002">S2B Fig</xref>), the reduction in activity is not sufficient to block cell growth in fission yeast [<xref ref-type="bibr" rid="pgen.1006041.ref038">38</xref>]. Addition of rapamycin to inhibit TORC1 activity in <italic>ppk32</italic>.<italic>Δ</italic> mutants abolished their sensitivity to 15μg ml<sup>−1</sup> BFA (<xref ref-type="fig" rid="pgen.1006041.g004">Fig 4B</xref>). Furthermore, inhibition of TORC1 in <italic>wild type</italic> cells with rapamycin promoted growth at a higher BFA concentration (20μg ml<sup>−1</sup>) (<xref ref-type="fig" rid="pgen.1006041.g004">Fig 4B</xref>).</p>
<fig id="pgen.1006041.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006041.g003</object-id>
<label>Fig 3</label>
<caption>
<title>TOR signalling is reduced by BFA-induced stress.</title>
<p>All strains are leucine autotrophs. (A, B) Early exponential cells were grown in rich medium (YES) with addition of Brefeldin A (BFA). Western blot analysis of Maf1.PK (A) or Ser546 Gad8 phosphorylation (B). Ponceau S staining was used as a loading control.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.g003" xlink:type="simple"/>
</fig>
<fig id="pgen.1006041.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006041.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Decreased TORC1 signalling promotes survival during BFA-induced Golgi stress.</title>
<p>All strains are leucine autotrophs. (A-E) Growth assays. Exponentially grown cells of the indicated strains were spotted in 10-fold serial dilution onto rich medium plates (YES) supplemented with BFA, BFA and rapamycin or vehicle (DMSO) alone. (F) Western blot analysis of Ppk32 levels. Early exponential cells were grown in rich medium (YES) with addition of Brefeldin A (BFA). Ponceau S staining was used as a loading control.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.g004" xlink:type="simple"/>
</fig>
<p>Rapamycin inhibits TORC1 activity when in a complex with FKBP12 [<xref ref-type="bibr" rid="pgen.1006041.ref003">3</xref>] (known as Fkh1 in fission yeast [<xref ref-type="bibr" rid="pgen.1006041.ref029">29</xref>]). To determine whether the impact of Rapamycin on BFA sensitivity was an indirect one of drug interference in which rapamycin affected BFA uptake, and thus bioavailability, we exposed <italic>fkh1</italic>.<italic>Δ</italic> mutants to BFA stress. However, the fact that, in contrast to wild type cells, rapamycin did not enhance growth of BFA treated <italic>fkh1</italic>.<italic>Δ</italic> mutants (<xref ref-type="supplementary-material" rid="pgen.1006041.s005">S5A Fig</xref>), excludes the possibility that rapamycin blocked BFA uptake. We therefore conclude that it is the reduction in TORC1 activity that promotes growth upon BFA induced stress.</p>
<p>Addition of Torin1 to inhibit both TORC1 and TORC2, also enhanced cell survival during BFA induced stress (<xref ref-type="supplementary-material" rid="pgen.1006041.s005">S5B Fig</xref>). 20μg ml<sup>−1</sup> BFA blocked growth of <italic>ppk32</italic>.<italic>Δ</italic> mutants. Addition of Torin1, but not rapamycin, liberated this block to cell growth (<xref ref-type="fig" rid="pgen.1006041.g004">Fig 4B</xref>, <xref ref-type="supplementary-material" rid="pgen.1006041.s005">S5B Fig</xref>). As mentioned previously, rapamycin reduces but does not completely block TORC1 activity (<xref ref-type="supplementary-material" rid="pgen.1006041.s002">S2B Fig</xref>), whereas a complete block of TORC1 activity is achieved by treatment with Torin1 [<xref ref-type="bibr" rid="pgen.1006041.ref024">24</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref026">26</xref>]. This may explain the increased potency of Torin1 over rapamycin in combination with BFA. Alternatively a combined reduction of TORC1 and TORC2 activity may be beneficial for survival following BFA induced stress.</p>
<p>We next exposed TORC2 deficient mutants to BFA to assess the role of TORC2 in BFA induced stress. Both <italic>tor1</italic>.<italic>Δ</italic> and <italic>tor1</italic>.<italic>Δ ppk32</italic>.<italic>Δ</italic> double mutants were sensitive to BFA and the TORC2 specific mutant <italic>ste20</italic>.<italic>Δ</italic> was hyper-sensitive to BFA (<xref ref-type="fig" rid="pgen.1006041.g004">Fig 4C and 4D</xref>). Furthermore, the constitutively active TORC2 mutant <italic>tor1</italic>.<italic>I1816T</italic> [<xref ref-type="bibr" rid="pgen.1006041.ref039">39</xref>] was also hyper sensitive to BFA (<xref ref-type="fig" rid="pgen.1006041.g004">Fig 4E</xref>). This suggests that TORC2 activity is essential for cell fitness during BFA induced stress, but only at moderate levels. Interestingly, BFA resistance was restored in the <italic>tor1</italic>.<italic>I1816T ppk32</italic>.<italic>Δ</italic> double mutant (<xref ref-type="fig" rid="pgen.1006041.g004">Fig 4E</xref>), suggesting that the hypersensitivity of the constitutively active TORC2 mutant <italic>tor1</italic>.<italic>I1816T</italic> is, at least partially, Ppk32 dependent. When considered together these observations indicate that the BFA-induced decrease, but not full inhibition, in TORC2 activity (<xref ref-type="fig" rid="pgen.1006041.g003">Fig 3B</xref>) that we observed in wild type cells may be important for cell survival. Finally, neither BFA treatment nor the presence of the <italic>tor1</italic>.<italic>I1816T</italic> mutation had any impact on Ppk32 protein levels (<xref ref-type="fig" rid="pgen.1006041.g004">Fig 4F</xref>, <xref ref-type="supplementary-material" rid="pgen.1006041.s006">S6A Fig</xref>).</p>
<p>In summary, our data demonstrate that enhanced TORC1 activity accounts for the BFA sensitivity of <italic>ppk32</italic>.<italic>Δ</italic> mutants. Decreased TORC1 activity promoted cell survival and recovery from BFA induced stress.</p>
</sec>
<sec id="sec007">
<title>Ppk32 controls TORC1 signalling during sexual cell differentiation</title>
<p>Human SCYL1 regulates retrograde traffic to modulate Golgi homeostasis [<xref ref-type="bibr" rid="pgen.1006041.ref015">15</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref022">22</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref035">35</xref>], whereas SCYL2 regulates clathrin-mediated endocytosis [<xref ref-type="bibr" rid="pgen.1006041.ref040">40</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref041">41</xref>]. Despite the high level of similarity between SCYL2 and Ppk32, <italic>ppk32</italic>.<italic>Δ</italic> cells were proficient for endocytosis. FM4-64 is a lipophilic dye that incorporates into the plasma and vacuolar membranes via endocytosis [<xref ref-type="bibr" rid="pgen.1006041.ref042">42</xref>]. FM4-64 staining of vacuoles in <italic>ppk32</italic>.<italic>Δ</italic> mutants (<xref ref-type="fig" rid="pgen.1006041.g005">Fig 5A</xref>) identified a modest increase in vacuolar size to suggest that an absence of <italic>ppk32</italic> expression favours vacuole fusion and/or diminishes vacuolar fission.</p>
<fig id="pgen.1006041.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006041.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Ppk32 controls TORC1 signalling during sexual cell differentiation.</title>
<p>All strains are leucine autotrophs. (A) Vacuole visualisation. Left-hand side: exponential cells of indicated strains that had been grown in YES were incubated with FM4-64 lipid dye for 30 min. Right-hand side: quantification of vacuole size distribution within the cultures. For each strain at least 500 vacuoles were measured. (B) Western blot analysis of Maf1.PK phosphorylation. Early exponential cells were grown in rich medium (YES) and shifted into sporulation liquid (SPL). Ponceau S staining was used as a loading control. (C) Mating efficiency. Exponentially YES-grown homothallic strains of opposite mating types were mixed in ratio 1:1 and spotted onto SPA plates. After 8 hours fused cells were counted. (D) Halo assay. Exponentially YES-grown diploid tester strain was mixed with indicated <italic>h</italic><sup><italic>−</italic></sup> strains in ratio 200:1 and spotted onto MSA plates. After overnight incubation sporulated cells were stained with iodine vapor. (E) Quantification of halo size distribution in cultures in D.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.g005" xlink:type="simple"/>
</fig>
<p>In the presence of cells of both mating types nitrogen starvation induces sexual differentiation to promote cell fusion, meiosis and sporulation [<xref ref-type="bibr" rid="pgen.1006041.ref043">43</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref044">44</xref>]. Vacuoles play an important role during sexual differentiation through their participation in autophagy [<xref ref-type="bibr" rid="pgen.1006041.ref045">45</xref>]. Autophagy deficient mutants are sterile but can complete differentiation when nutrients are resupplied [<xref ref-type="bibr" rid="pgen.1006041.ref045">45</xref>]. High TORC1 signalling represses sexual differentiation [<xref ref-type="bibr" rid="pgen.1006041.ref005">5</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref027">27</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref046">46</xref>]. The inhibition of TORC1 signalling, arising from nutrient starvation induces differentiation and so promotes cell fusion. Importantly however, TORC1 signalling must be reinstated to support further differentiation because diploid mutants with deficiencies in the fission yeast raptor, Mip1, are unable to execute meiosis and sporulation [<xref ref-type="bibr" rid="pgen.1006041.ref047">47</xref>]. Thus, after its initial repression has been triggered by nutrient reduction, TORC1 is reactivated by autophagy-supplied nutrients.</p>
<p>The survival of cells deleted for <italic>ppk32</italic> following prolonged periods of nutrient deprivation indicates that <italic>ppk32</italic>.<italic>Δ</italic> mutant cells are autophagy proficient (<xref ref-type="supplementary-material" rid="pgen.1006041.s006">S6B Fig</xref>). Nitrogen starvation promoted TORC1 inhibition in both <italic>wt</italic> and in <italic>ppk32</italic>.<italic>Δ</italic> cells (<xref ref-type="fig" rid="pgen.1006041.g005">Fig 5B</xref>), however TORC1 activity returned more rapidly to <italic>ppk32</italic>.<italic>Δ</italic> cells (<xref ref-type="fig" rid="pgen.1006041.g005">Fig 5B</xref>) and sexual differentiation was increased by a further 10% eight hours after starvation (<xref ref-type="fig" rid="pgen.1006041.g005">Fig 5C</xref>). Pheromone secretion was also enhanced in <italic>ppk32</italic>.<italic>Δ</italic> mutant cells (<xref ref-type="fig" rid="pgen.1006041.g005">Fig 5D</xref>). A “halo assay” can be used as a proxy for pheromone secretion. It deploys a diploid tester strain that cannot sporulate unless external pheromone (M-factor) is supplied [<xref ref-type="bibr" rid="pgen.1006041.ref048">48</xref>]. Sporulating diploid tester strains can be visualized because the starch in their spore walls generates a dark stain when exposed to iodine vapour. Mixing a tester strain with <italic>wt</italic> or <italic>ppk32</italic>.<italic>Δ</italic> mating partners at a ratio of 200:1 revealed increased pheromone secretion from <italic>ppk32</italic>.<italic>Δ</italic> cells (<xref ref-type="fig" rid="pgen.1006041.g005">Fig 5D and 5E</xref>). In summary, the presence of Ppk32 during sexual differentiation retards TORC1 reactivation to delay sexual differentiation.</p>
</sec>
<sec id="sec008">
<title>Ppk32 phosphorylation controls protein levels and function during BFA induced stress</title>
<p>Global phosphoproteomic approaches have revealed that Ppk32 is phosphorylated on the carboxyl terminal Serine 630 and Serine 632 [<xref ref-type="bibr" rid="pgen.1006041.ref049">49</xref>–<xref ref-type="bibr" rid="pgen.1006041.ref051">51</xref>]. These phosphorylation sites are conserved throughout the SCYL family of kinases (<xref ref-type="fig" rid="pgen.1006041.g006">Fig 6A</xref>) but are not present in the other fission yeast SCYL homolog Ppk3 that has no impact upon sensitivity to Torin1 (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1C</xref>). To assess the significance of phosphorylation on Ser630 and Ser632 upon the function of <italic>S</italic>. <italic>pombe</italic> Ppk32, the endogenous <italic>ppk32</italic><sup>+</sup> locus was manipulated to simultaneously mutate both sites to either alanine to block signalling or to aspartic acid to mimic constitutive phosphorylation. Ppk32 could not be detected in the <italic>ppk32</italic>.<italic>DD (ppk32</italic>.<italic>S630D-S632D)</italic> mutant whereas levels were modestly enhanced in <italic>ppk32</italic>.<italic>AA (ppk32</italic>.<italic>S630A-S632A)</italic> cells (<xref ref-type="fig" rid="pgen.1006041.g006">Fig 6B</xref>). Both mutations elevated tolerance to Torin1 (<xref ref-type="fig" rid="pgen.1006041.g006">Fig 6C</xref>). The low Ppk32 levels in the <italic>ppk32</italic>.<italic>DD</italic> mutants are reminiscent of a <italic>ppk32</italic>.<italic>Δ</italic> and thereby account for the Torin1 resistance of this mutant. In contrast, the resistance to Torin1 of <italic>ppk32</italic>.<italic>AA</italic> is unlikely to arise from changes in protein level. Interestingly, comparisons with wild type controls revealed that the phosphoblocking mutation <italic>ppk32</italic>.<italic>AA</italic> reduced the amount of Ppk32 that immuno-precipitated with Tor1 (<xref ref-type="fig" rid="pgen.1006041.g006">Fig 6D</xref>). Thus, phosphorylation at these residues appears to modulate the affinity of Ppk32 for Tor1. In line with the imposed resistance to Torin1, both phosphorylation site mutants conferred sensitivity to BFA induced stress (<xref ref-type="fig" rid="pgen.1006041.g006">Fig 6C</xref>), to further support the view that phosphorylation is important for protein function.</p>
<fig id="pgen.1006041.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006041.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Ppk32 function is regulated by conserved phosphorylation.</title>
<p>All strains are leucine autotrophs. (A). Sequence alignment between Ppk32 and other SCYL family kinases. (B) Early exponential cells were grown in rich medium (YES). Samples from non-stressed cultures were taken for Western blot analysis of Ppk32 level. Ponceau S staining was used as a loading control, * indicates a background band. (C) Growth assay. Exponentially YES-grown cells of indicated strains were spotted in 10-fold serial dilution onto the indicated media. (D) Tor1 immuno-precipitations first 3 lanes (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1</xref>) are shown again for comparison. Soluble proteins were extracted from exponentially grown strains. Tor1 immuno-precipites and Ppk32 co-immuno-precipites were assessed from the same gels. The relative levels of specific Ppk32 immuno-precipitation are shown. (E-F) Early exponential indicated strains were grown in minimal media (EMMG) to achieve Ppk32 over-expression. Shifted from 28°C to 37°C to induce heat stressed (F) Western blot analysis of phosphorylated S630 and S632 of Ppk32 and total Ppk32 levels. (G) Quantification of relative Ppk32 S630 and S632 phosphoryaliton after 4 hours heat stress.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.g006" xlink:type="simple"/>
</fig>
<p>Next, phospho-specific antibodies that recognise Ppk32 when phosphorylated on both S630 and S632 were generated by Eurogentec (<xref ref-type="supplementary-material" rid="pgen.1006041.s007">S7A Fig</xref>). Consistent with the inability to detect any Ppk32 in the <italic>ppk32</italic>.<italic>DD</italic> mutant (<xref ref-type="fig" rid="pgen.1006041.g006">Fig 6B</xref>) we were unable to detect Ppk32 phosphorylation in wild type cells (<xref ref-type="fig" rid="pgen.1006041.g006">Fig 6E</xref>). To facilitate the detection of Ppk32 phosphorylation <italic>ppk32</italic><sup><italic>+</italic></sup> was over-expressed from the <italic>nmt1</italic> promoter [<xref ref-type="bibr" rid="pgen.1006041.ref052">52</xref>] (<xref ref-type="fig" rid="pgen.1006041.g006">Fig 6E</xref>) in wild type cells and TORC1 deficient <italic>tor2</italic>.<italic>ts</italic> mutants that had been subjected to heat stress at 37°C (<xref ref-type="fig" rid="pgen.1006041.g006">Fig 6F</xref>). Comparison of Ppk32 phosphorylation with Ppk32 total proteins levels in these heat stressed cells revealed that phosphorylated Ppk32 was degraded in wild type cells, but not in the TORC1 deficient <italic>tor2</italic>.<italic>ts</italic> mutant (<xref ref-type="fig" rid="pgen.1006041.g006">Fig 6F and 6G</xref> &amp; <xref ref-type="supplementary-material" rid="pgen.1006041.s007">S7B Fig</xref>). When considered alongside the TORC1 dependent turnover of wild type Ppk32 (<xref ref-type="fig" rid="pgen.1006041.g002">Fig 2A</xref>), these data suggest that TORC1 activity promotes the degradation of phosphorylated Ppk32.</p>
</sec>
<sec id="sec009">
<title>The Ppk32 carboxy terminus is required for function</title>
<p>The regions adjacent to the Ser630 and Ser632 phosphorylation sites reside in the part of the protein that is most highly conserved in human SCYL1 (<xref ref-type="fig" rid="pgen.1006041.g006">Fig 6A</xref>). The carboxy terminal RKXX-COO<sup>−</sup> motif of SCYL1 binds to coatomer (a COP1 protein complex in an ARF independent manner to regulate retrograde transport and Golgi morphology) [<xref ref-type="bibr" rid="pgen.1006041.ref022">22</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref036">36</xref>]. This SCYL1 RKXX motif and the sourounding sequence is partly conserved in Ppk32 (<xref ref-type="fig" rid="pgen.1006041.g007">Fig 7A</xref>). Ppk32 has a mono-basic motif followed by a serine in place of the di-basic motif found in SCYL1 (<xref ref-type="fig" rid="pgen.1006041.g007">Fig 7A</xref>). Non-conventional mono basic motifs have previously been shown to promote binding to COP proteins [<xref ref-type="bibr" rid="pgen.1006041.ref053">53</xref>]. To assess the significance of Ppk32 carboxy-terminal sequence Lys745 and Ser746 they were simultaneously mutated to alanine at the native locus to generate the <italic>ppk32</italic>.<italic>L745A-S746A (ppk32</italic>.<italic>AAXX</italic>) allele (<xref ref-type="fig" rid="pgen.1006041.g007">Fig 7A</xref>). Ppk32 protein levels were unaffected by the presence of the <italic>ppk32</italic>.<italic>AAXX</italic> allele (<xref ref-type="fig" rid="pgen.1006041.g007">Fig 7B</xref>), however, the mutant gene conferred both resistance to Torin1 and sensitivity to BFA (<xref ref-type="fig" rid="pgen.1006041.g007">Fig 7C</xref>). Thus, the Ppk32 carboxy-terminal domain of Ppk32 is required for function.</p>
<fig id="pgen.1006041.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006041.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Ppk32 carboxy-terminus is important for protein function.</title>
<p>All strains are leucine autotrophs. (A). Sequence alignment of the carboxy terminus of Ppk32 and other SCYL family kinases. (B) Early exponential cells were grown in rich medium (YES). Samples from non-stress cultures were taken for Western blot analysis of Ppk32 level. Ponceau S staining was used as a loading control, * indicates a background band. (C) Growth assay. Exponentially YES-grown cells of indicated strains were spotted in 10-fold serial dilution onto the indicated media. (D) Schematic (1) suggesting that both TORC1 and TORC2 regulate Ppk32 levels. Schematic (2) suggesting that Ppk32 phosphorylation and its carboxy terminus are essential to control TORC1 following BFA induced stress.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.g007" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec010" sec-type="conclusions">
<title>Discussion</title>
<p>Here we describe a novel control of TORC1 signalling by the SCYL family pseudo-kinase Ppk32 that is essential for survival following BFA induced stress. As the impact of BFA on cell growth that we report here is unlikely to arise from ER Stress (<xref ref-type="supplementary-material" rid="pgen.1006041.s004">S4A Fig</xref>), it probably arises from either Golgi stress or impaired traffic to lysosomes. It is the response to this stress that requires Ppk32 dependent control of TORC1 activity. Interestingly the system appears to involve negative feedback from TOR to Ppk32 as TOR signalling regulates Ppk32 protein levels (summarised in <xref ref-type="fig" rid="pgen.1006041.g007">Fig 7D1</xref>). At present, it is unclear where in the cell this TOR mediated control of Ppk32 protein levels occurs and where Ppk32 control of TOR signalling takes place.</p>
<p>We show that Ppk32 phosphorylation on two conserved residues is important for protein function. Ppk32 phosphorylation dramatically reduced protein levels and conferred resistance to TOR inhibition. Similarly, despite the increase in protein levels that arises as a consequence of an inability to phosphorylate Ppk32, lack of phosphate on these residues provides resistance to TOR inhibition and highlights the functional significance of these phosphorylation events. Importantly our data suggest that Ppk32 phosphorylation promotes the association of Ppk32 with Tor1.</p>
<p>The impact of Ppk32 on global TOR signalling in non-stressed, steady state conditions is small but measurable, as Ppk32 deficient cells are resistant to Torin1 induced inhibition of TOR signalling (<xref ref-type="fig" rid="pgen.1006041.g001">Fig 1C</xref>). Our data show how this impact on TOR signalling is dependent on the composition of growth media. A previous report has described an impact of media composition (rather than starvation) on cell growth and chronological lifespan (a process regulated by TOR signalling) to suggest that the steady state level of TOR signalling is regulated by the nutrient composition [<xref ref-type="bibr" rid="pgen.1006041.ref054">54</xref>]. We found that Ppk32 deficient cells that were autotrophic for leucine biosynthesis displayed increased resistance to Torin1. Leucine is a well-known activator of TOR signalling in a process that occurs on the endomembranes of vacuoles (yeast lysosomes) [<xref ref-type="bibr" rid="pgen.1006041.ref055">55</xref>]. TORC1 concentrates on vacuolar endomembranes [<xref ref-type="bibr" rid="pgen.1006041.ref020">20</xref>]. Activation of TORC1 by the addition of leucine may be more efficient in <italic>ppk32</italic>.<italic>Δ</italic> cells because these cells lack an apparent inhibitor of TOR signaling. However, whether phosphorylated Ppk32 interacts with vacuolar TORC1 is unclear at present.</p>
<p>Ppk32 shares sequence similarity with both human SCYL family kinases. However, the requirement of the Ppk32 C-terminal for survival following BFA induced stress and the fact that lack of <italic>ppk32</italic><sup><italic>+</italic></sup> expression has no impact on endocytosis (a SCYL2 function) suggests that, despite slightly higher level of homology to SCYL2, Ppk32 appears to be a functional SCYL1 homologue in the context of BFA induced stress.</p>
<p>It is unclear whether Ppk32 localizes to the Golgi or COPI budding vesicles. In fission yeast Golgi localisation is seen as small cytoplasmic foci [<xref ref-type="bibr" rid="pgen.1006041.ref056">56</xref>]. We did observed small foci in the cytoplasm, however the molecular composition of these is unclear at present. A systematic screen of protein localizations in fission yeast, reported the recruitment of an over-expressed Ppk32 protein to Golgi-like structures [<xref ref-type="bibr" rid="pgen.1006041.ref057">57</xref>], suggesting that Ppk32 may localize to the Golgi in fission yeast. Interestingly The RSXX carboxy-terminal motif of Ppk32 is important for cells to tolerate BFA induced stress. Because mTORC1 is localized to the Golgi [<xref ref-type="bibr" rid="pgen.1006041.ref058">58</xref>] and to lysosomes [<xref ref-type="bibr" rid="pgen.1006041.ref055">55</xref>], phosphorylated Ppk32 may facilitate control of TORC1 signalling on either endomembrane system, however this is unclear at present. Localized control of TORC1 activity would explain why a lack of <italic>ppk32</italic><sup><italic>+</italic></sup> expression had no impact on TORC1 control of Maf1 (cytoplasmic protein) phosphorylation. Future EM based localisation with specific Ppk32 antibodies will determine whether Ppk32 resides on the Golgi and on vacuoles.</p>
<p>SCYL1 regulates both retrograde trafficking of COPI-coated vesicles from Golgi to ER and transport between Golgi stacks [<xref ref-type="bibr" rid="pgen.1006041.ref022">22</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref035">35</xref>]. Recently SCYL1 was shown to act as a scaffold that supports the interaction between ARFs and COPI complexes [<xref ref-type="bibr" rid="pgen.1006041.ref036">36</xref>]. BFA inhibits the GEFs for class II ARFs [<xref ref-type="bibr" rid="pgen.1006041.ref016">16</xref>,<xref ref-type="bibr" rid="pgen.1006041.ref017">17</xref>] to release ARF into the cytosol. We show that Ppk32 controlled TORC1 inhibition following BFA induced stress was essential for survival. This Ppk32 controlled reduction in TORC1 signalling will slow down cell metabolism and proliferation. This impairment of metabolism is likely to assist recovery from stress to the membrane traffic system and therefore support survival of BFA stressed cells (summarised in <xref ref-type="fig" rid="pgen.1006041.g007">Fig 7D2</xref>). We show that a simultaneous reduction of TOR activity, by combining treatment with BFA with additional TOR inhibitors, enhanced cell recovery from BFA induced stress, irrespective of Ppk32 status. Interestingly, one hallmark of cancer is an alteration of the glycosylation landscape that arises from modified Golgi function. Our findings suggest that therapeutic rapamycin treatment to reduce TORC1 signalling and proliferation of cancer cells that are experiencing inherent Golgi stress, might actually have the unintended consequence of enhancing cell survival. It is notable therefore that the control of phosphorylation at the sites in SCYL1, that are equivalent to those identified in fission yeast Ppk32, would be predicted to reduce SCYL1 protein levels and so increase cell death and treatment of cancer types with inherent Golgi stress.</p>
</sec>
<sec id="sec011" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec012">
<title>Cell cultures and strains</title>
<p>Strains used in this study are listed in <xref ref-type="table" rid="pgen.1006041.t001">Table 1</xref>. Cells were exponentially grown for 36 hr at 28°C in YES [<xref ref-type="bibr" rid="pgen.1006041.ref059">59</xref>] 0.15 mg ml<sup>−1</sup> adenine hemisulphate, uracil, L-leucine and histidine (each), or for 48 hr at 28°C either EMM-G or EMM-P [<xref ref-type="bibr" rid="pgen.1006041.ref030">30</xref>]. L-leucine was added to a final concentration of 150 μg ml<sup>−1</sup>. For western blots and growth assays cells were grown to a density of 2×10<sup>6</sup> cells ml<sup>−1</sup>. For nutrient starvation cells were grown in YES and at the density of 2×10<sup>6</sup> cells ml<sup>−1</sup> cultures were filtered into sporulation liquid SPL [<xref ref-type="bibr" rid="pgen.1006041.ref060">60</xref>]. For mating assays, cells were grown to a density of 2×10<sup>6</sup> mixed in a ratio of 1:1 <italic>h</italic><sup><italic>+</italic></sup>:<italic>h</italic><sup><italic>−</italic></sup> 1.5x10<sup>6</sup> cells of each strain, washed with water and spotted onto SPA (SPL with 30 g l<sup>−1</sup> agar). Mating efficiency was calculated as [<xref ref-type="bibr" rid="pgen.1006041.ref061">61</xref>]. For halo assays, cells were grown to a density of 2×10<sup>6</sup> and mixed with <italic>h</italic><sup><italic>−</italic></sup> cell in ratio: 200:1, washed with water and spotted onto MSA [<xref ref-type="bibr" rid="pgen.1006041.ref048">48</xref>].</p>
<table-wrap id="pgen.1006041.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006041.t001</object-id>
<label>Table 1</label> <caption><title>Yeast strains used in this study.</title></caption>
<alternatives>
<graphic id="pgen.1006041.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"><italic>Strain number</italic></th>
<th align="left"><italic>genotype</italic></th>
<th align="justify"><italic>source</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify">JP164</td>
<td align="left"><italic>ppk3</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>leu1</italic>.<italic>32</italic></td>
<td align="justify"><italic>ppk3</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> From [<xref ref-type="bibr" rid="pgen.1006041.ref034">34</xref>]</td>
</tr>
<tr>
<td align="justify">JP305</td>
<td align="left"><italic>h</italic><sup><italic>−</italic></sup> <italic>leu1</italic>.<italic>32</italic></td>
<td align="justify">Lab stock</td>
</tr>
<tr>
<td align="justify">JP755</td>
<td align="left"><italic>fkh1</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>leu1</italic>.<italic>32</italic></td>
<td align="justify"><italic>fkh1</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> from [<xref ref-type="bibr" rid="pgen.1006041.ref029">29</xref>]</td>
</tr>
<tr>
<td align="justify">JP1293</td>
<td align="left"><italic>h</italic><sup><italic>−</italic></sup> <italic>tor1</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ura4</italic>.<italic>d18 leu1</italic>.<italic>32</italic></td>
<td align="justify">Lab stock</td>
</tr>
<tr>
<td align="justify">JP1960</td>
<td align="left"><italic>h</italic><sup><italic>−</italic></sup> <italic>ppk32</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ura4</italic>.<italic>d18 leu1</italic>.<italic>32</italic></td>
<td align="justify"><italic>ppk32</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> From [<xref ref-type="bibr" rid="pgen.1006041.ref034">34</xref>]</td>
</tr>
<tr>
<td align="justify">JP2047</td>
<td align="left"><italic>h</italic><sup><italic>−</italic></sup> <italic>ppk32</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ura4</italic>.<italic>d18</italic></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP2131</td>
<td align="left"><italic>maf1</italic>.<italic>PK</italic>:<italic>kanMx6 leu1</italic>.<italic>32</italic></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP2404</td>
<td align="left"><italic>ade6</italic>.<italic>M210/ade6</italic>.<italic>M216 mat2</italic>,<italic>3</italic>::<italic>leu2/mat2</italic>,<italic>3</italic>::<italic>leu2 leu1</italic>.<italic>32/leu1</italic>.<italic>32 ura4</italic>.<italic>d18/ura4</italic>.<italic>d18 mat1-MC</italic>::<italic>ura4</italic><sup><italic>+</italic></sup><italic>/MAT1 MAT1/mat1-P</italic></td>
<td align="justify">[<xref ref-type="bibr" rid="pgen.1006041.ref048">48</xref>]</td>
</tr>
<tr>
<td align="justify">JP2450</td>
<td align="left"><italic>ppk4</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ura4</italic>.<italic>d18 leu1</italic>.<italic>32</italic></td>
<td align="justify"><italic>ppk4</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> From [<xref ref-type="bibr" rid="pgen.1006041.ref034">34</xref>]</td>
</tr>
<tr>
<td align="justify">JP2458</td>
<td align="left"><italic>maf1</italic>.<italic>PK</italic>:<italic>kanMx6 ppk32</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ura4</italic>.<italic>d18 leu1</italic>.<italic>32</italic></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP2480</td>
<td align="left"><italic>tor2</italic>.<italic>51</italic>:<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ppk32</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ura4</italic>.<italic>d18 leu1</italic>.<italic>32</italic></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP2495</td>
<td align="left"><italic>ste20</italic>::<italic>kanMx6 leu1</italic>.<italic>32</italic></td>
<td align="justify"><italic>ste20</italic>::<italic>kanMx6</italic> from [<xref ref-type="bibr" rid="pgen.1006041.ref064">64</xref>]</td>
</tr>
<tr>
<td align="justify">JP2502</td>
<td align="left"><italic>ppk4</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ppk32</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ura4</italic>.<italic>d18 leu1</italic>.<italic>32</italic></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP2503</td>
<td align="left"><italic>h</italic><sup><italic>+</italic></sup> <italic>ppk32</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ura4</italic>.<italic>d18 leu1</italic>.<italic>32</italic></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP2504</td>
<td align="left"><italic>h</italic><sup><italic>−</italic></sup> <italic>leu1</italic>.<italic>32 + pRep1—nmt1</italic>:<italic>leu1</italic><sup><italic>+</italic></sup></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP2512</td>
<td align="left"><italic>h</italic><sup><italic>−</italic></sup> <italic>leu1</italic>.<italic>32 + pRep1 –nmt1-ppk32</italic>:<italic>leu</italic><sup><italic>+</italic></sup></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP2514</td>
<td align="left"><italic>h</italic><sup><italic>+</italic></sup> <italic>leu1</italic>.<italic>32</italic></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP2659</td>
<td align="left"><italic>tor1</italic>.<italic>I1816T leu1</italic>.<italic>32</italic></td>
<td align="justify"><italic>tor1</italic>.<italic>I1816T</italic> from [<xref ref-type="bibr" rid="pgen.1006041.ref039">39</xref>]</td>
</tr>
<tr>
<td align="justify">JP2709</td>
<td align="left"><italic>tor2</italic>.<italic>51</italic>:<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ura4</italic>.<italic>d18 leu1</italic>.<italic>32</italic></td>
<td align="justify"><italic>tor2</italic>.<italic>51</italic>:<italic>ura4</italic><sup><italic>+</italic></sup> from [<xref ref-type="bibr" rid="pgen.1006041.ref005">5</xref>]</td>
</tr>
<tr>
<td align="justify">JP2711</td>
<td align="left"><italic>tor1</italic>.<italic>I1816T ppk32</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ura4</italic>.<italic>d18 leu1</italic>.<italic>32</italic></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP2882</td>
<td align="left"><italic>ppk3</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>ppk32</italic>::<italic>ura4</italic><sup><italic>+</italic></sup> <italic>leu1</italic>.<italic>32</italic></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP3061</td>
<td align="left"><italic>ppk32</italic>.<italic>S630D-S632D leu1</italic>.<italic>32</italic></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP3116</td>
<td align="left"><italic>ppk32</italic>.<italic>S630A-S632A leu1</italic>.<italic>32</italic></td>
<td align="justify">This study</td>
</tr>
<tr>
<td align="justify">JP3094</td>
<td align="left"><italic>ppk32</italic>.<italic>AAXX leu1</italic></td>
<td align="justify">This study</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>The <italic>ppk32</italic> open reading frame was amplified by PCR from genomic <italic>wt</italic> DNA, sequenced and cloned into Nde1 of the pRep1 plasmid to facilitate Ppk32 overexpression from the <italic>nmt1</italic> promoter [<xref ref-type="bibr" rid="pgen.1006041.ref052">52</xref>]</p>
</sec>
<sec id="sec013">
<title>Microscopy</title>
<p>In order to analyse vacuoles morphology, cells were grown in YES to the density of 1.8 × 10<sup>6</sup> cells ml<sup>−1</sup> before FM4-64 dye 5mg/ml was added to the culture in ratio: 1:10 000 (dye:culture, v/v) and cells were incubated further. After 30 min, stained vacuoles in live cells were analyzed under the microscope. For each culture at least 500 vacuoles were measured.</p>
</sec>
<sec id="sec014">
<title>Biochemistry</title>
<p>Total protein extracts were prepared by TCA precipitation [<xref ref-type="bibr" rid="pgen.1006041.ref062">62</xref>].</p>
<p>For Tor1 IP, 3x10<sup>8</sup> cells (culture density 2,4x10<sup>6</sup> cells ml<sup>−1</sup>) were harvested and re-suspended in IP buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 0,1% CHAPS, 0,05% Tween20, 50 mM L-arginine, 50 mM L-glutamic acid, 50 mM NaF, 2 mM NaVO<sub>4</sub>, 60 mM sodium glycerol phosphate, 5 mM NEM, 1 mM PMSF, 1 mM DTT and Sigma protease inhibitor cocktail) and broken in a FastPrep using glass beads. The cell extract was spun (10 000 rpm, 10 min, 4°C) and supernatant was incubated with Invitrogen protein Dynabeads pre-coupled with anti-Tor1, anti-V5 (PK) or anti-myc antibodies for 20 min at 4°C. Beads were then washed three times with IP buffer and heated to 80°C for 10 min to elute the proteins. Samples were loaded on a SDS-PAGE gel and subsequently processed as total protein extracts.</p>
<p>Proteins were detected using the following antibodies: 1:2000 anti-Ppk32 (polyclonal antibodies raised by Eurogentec Ltd to the following peptide PSEARTPSVQPANRR in rabbits), 1:2000 anti-V5 (anti-PK) (AbD Serotec), 1:1000 anti-phospho Ser546 Gad8 [<xref ref-type="bibr" rid="pgen.1006041.ref026">26</xref>], 1:100 Gad8 [<xref ref-type="bibr" rid="pgen.1006041.ref026">26</xref>], 1:1000 anti-Tor1 [<xref ref-type="bibr" rid="pgen.1006041.ref039">39</xref>], 1:2000 anti-PAS (Cell Signaling Technology), 1:2000 anti-Rps6 (Abcam), anti-phospho-Ser630 S632 Ppk32 (generated by Eurogentec). Alkaline phosphatase coupled secondary antibodies were used for all blots, followed by direct detection with NBT/BCIP (VWR International Ltd.) substrates on PVDF membranes (Millipore). Ponceau S staining was used as a loading control [<xref ref-type="bibr" rid="pgen.1006041.ref063">63</xref>]. Relative protein levels were quantified in ImageJ and GraphPad Prism was used to calculated significant differences. Asterisks represent statistical significance (p&lt;0.05) as determined by a Student’s t-test.</p>
</sec>
</sec>
<sec id="sec015">
<title>Supporting Information</title>
<supplementary-material id="pgen.1006041.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Ppk32 deficient cells are proficient for Torin1 uptake.</title>
<p>All strains are leucine autotrophs. (A,B,D) Western blot analysis: Early exponential cells were grown in rich medium (YES) with addition of increasing Torin1 concentration (D). Samples from indicated cultures were taken for Western blot analysis of Ppk32 level, * indicates a background band. (C) Growth assay. Exponentially YES-grown cells of indicated strains were spotted in 10-fold serial dilution onto the indicated media. (E) Early exponential cells were grown in rich medium (YES) or minimal medium (EMMG). Samples from non-stressed cultures were taken for Western blot analysis of Ppk32 levels. Phos-tag was added to the gel to reveal that Ppk32.PK is phosphorylated. Ponceau S staining was used as a loading control.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pgen.1006041.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Heat stress regulates TORC1.</title>
<p>All strains are leucine autotrophs. (A,B) Early exponential cells were grown in rich medium (YES) and shifted into 37°C (A) or treated with Rapamycin (B). Samples were taken for Western blot analysis of Maf1.PK levels of phosphorylation. Ponceau S staining was used as a loading control. (C) Early exponential cells were grown in rich medium (YES). Samples from non-stressed cultures were taken for Western blot analysis of Ppk32 levels. Ponceau S staining was used as a loading control.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pgen.1006041.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.s003" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Ppk32 inhibits growth and TOR signalling.</title>
<p>(A, B) Early exponential cells expressing <italic>ppk32</italic> from the <italic>nmt1</italic> promoter or transformed with an empty vector were grown in minimal medium (EMMG) with (low) or without (high) the addition of 10 μM thiamine. (A) Growth assay. Early exponential cultures were spotted in 10-fold dilution onto the indicated media (low = with thiamine) or (high = without thiamine). (B) Samples were taken for Western blot analysis of Ppk32 level, Maf1.PK and Ser546 Gad8 phosphorylation. Ponceau S staining was used as a loading control.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pgen.1006041.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.s004" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>BFA sensitivity of fission yeast does not arise from ER stress.</title>
<p>(A) Growth assay. Exponentially YES-grown cells of indicated strains were spotted in 10-fold serial dilution onto the indicated media to assess cell fitness.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pgen.1006041.s005" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.s005" xlink:type="simple">
<label>S5 Fig</label>
<caption>
<title>Torin1 promotes cell growth in the presence of BFA.</title>
<p>(A,B) Growth assay. Exponentially YES-grown cells of indicated strains were spotted in 10-fold serial dilution onto the indicated media to assess cell fitness.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pgen.1006041.s006" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.s006" xlink:type="simple">
<label>S6 Fig</label>
<caption>
<title><italic>ppk32</italic>.<italic>Δ</italic> mutant cells are autophagy proficient.</title>
<p>(A) Western blot analyses of Ppk32. Early exponential cells were grown in rich medium (YES). Samples from indicated cultures were subjected to Western blot, * indicates a background band. (B) Growth assay. Exponentially grown cells were deprived of nitrogen by shifting from MSL+Nitrogen into MSL-Nitrogen medium and spotted in 10-fold serial dilution onto YES plates at the indicated time points.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pgen.1006041.s007" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006041.s007" xlink:type="simple">
<label>S7 Fig</label>
<caption>
<title>Phospho-Ppk32.S630-S632 antibodies are phosphor-specific.</title>
<p>(A, B) Western blot analyses of phospho-Ppk32. Early exponential cells expressing <italic>ppk32</italic> from the <italic>nmt1</italic> promoter were grown in minimal medium (EMMG) without the addition of thiamine for 20 hr (high expression). (A) Soluble total protein extracts were exposed to Lambda phosphatase with or without the addition of phosphatase inhibitors. (B) A <italic>tor2</italic>.<italic>51</italic> mutant were shifted to 37°C for 3 hr to inactivate TORC1. The level of phosphorylated Ppk32 increases when TORC1 is inactivated.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Iain Hagan, Martin Lowe and members of the laboratory for stimulating discussions, Iain Hagan for comments on the manuscript and Lenka Halova for assistance with live cell imaging.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pgen.1006041.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shimobayashi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hall</surname> <given-names>MN</given-names></name> (<year>2014</year>) <article-title>Making new contacts: the mTOR network in metabolism and signalling crosstalk</article-title>. <source>Nature reviews Molecular cell biology</source> <volume>15</volume>: <fpage>155</fpage>–<lpage>162</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrm3757" xlink:type="simple">10.1038/nrm3757</ext-link></comment> <object-id pub-id-type="pmid">24556838</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Sarbassov</surname> <given-names>DD</given-names></name>, <name name-style="western"><surname>Ali</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>King</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Latek</surname> <given-names>RR</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery</article-title>. <source>Cell</source> <volume>110</volume>: <fpage>163</fpage>–<lpage>175</lpage>. <object-id pub-id-type="pmid">12150925</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Loewith</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Jacinto</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Wullschleger</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lorberg</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Crespo</surname> <given-names>JL</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control</article-title>. <source>Molecular cell</source> <volume>10</volume>: <fpage>457</fpage>–<lpage>468</lpage>. <object-id pub-id-type="pmid">12408816</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sarbassov</surname> <given-names>DD</given-names></name>, <name name-style="western"><surname>Ali</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Guertin</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Latek</surname> <given-names>RR</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton</article-title>. <source>Current biology: CB</source> <volume>14</volume>: <fpage>1296</fpage>–<lpage>1302</lpage>. <object-id pub-id-type="pmid">15268862</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alvarez</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Moreno</surname> <given-names>S</given-names></name> (<year>2006</year>) <article-title>Fission yeast Tor2 promotes cell growth and represses cell differentiation</article-title>. <source>Journal of cell science</source> <volume>119</volume>: <fpage>4475</fpage>–<lpage>4485</lpage>. <object-id pub-id-type="pmid">17046992</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayashi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hatanaka</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nagao</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nakaseko</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kanoh</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Rapamycin sensitivity of the Schizosaccharomyces pombe tor2 mutant and organization of two highly phosphorylated TOR complexes by specific and common subunits</article-title>. <source>Genes to cells: devoted to molecular &amp; cellular mechanisms</source> <volume>12</volume>: <fpage>1357</fpage>–<lpage>1370</lpage>.</mixed-citation></ref>
<ref id="pgen.1006041.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matsuo</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Otsubo</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Urano</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tamanoi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Yamamoto</surname> <given-names>M</given-names></name> (<year>2007</year>) <article-title>Loss of the TOR kinase Tor2 mimics nitrogen starvation and activates the sexual development pathway in fission yeast</article-title>. <source>Molecular and cellular biology</source> <volume>27</volume>: <fpage>3154</fpage>–<lpage>3164</lpage>. <object-id pub-id-type="pmid">17261596</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jacinto</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Loewith</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Schmidt</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ruegg</surname> <given-names>MA</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive</article-title>. <source>Nature cell biology</source> <volume>6</volume>: <fpage>1122</fpage>–<lpage>1128</lpage>. <object-id pub-id-type="pmid">15467718</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sarbassov</surname> <given-names>DD</given-names></name>, <name name-style="western"><surname>Guertin</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Ali</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Sabatini</surname> <given-names>DM</given-names></name> (<year>2005</year>) <article-title>Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex</article-title>. <source>Science</source> <volume>307</volume>: <fpage>1098</fpage>–<lpage>1101</lpage>. <object-id pub-id-type="pmid">15718470</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arias</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Koga</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Diaz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mocholi</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Patel</surname> <given-names>B</given-names></name>, <etal>et al</etal>. (<year>2015</year>) <article-title>Lysosomal mTORC2/PHLPP1/Akt Regulate Chaperone-Mediated Autophagy</article-title>. <source>Molecular cell</source> <volume>59</volume>: <fpage>270</fpage>–<lpage>284</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.molcel.2015.05.030" xlink:type="simple">10.1016/j.molcel.2015.05.030</ext-link></comment> <object-id pub-id-type="pmid">26118642</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sancak</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Peterson</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Shaul</surname> <given-names>YD</given-names></name>, <name name-style="western"><surname>Lindquist</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Thoreen</surname> <given-names>CC</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1</article-title>. <source>Science</source> <volume>320</volume>: <fpage>1496</fpage>–<lpage>1501</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1157535" xlink:type="simple">10.1126/science.1157535</ext-link></comment> <object-id pub-id-type="pmid">18497260</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomas</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>YH</given-names></name>, <name name-style="western"><surname>Cho</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Morris</surname> <given-names>LE</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Rab1A is an mTORC1 activator and a colorectal oncogene</article-title>. <source>Cancer cell</source> <volume>26</volume>: <fpage>754</fpage>–<lpage>769</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ccell.2014.09.008" xlink:type="simple">10.1016/j.ccell.2014.09.008</ext-link></comment> <object-id pub-id-type="pmid">25446900</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boulbes</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Shaiken</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sarbassov dos</surname> <given-names>D</given-names></name> (<year>2011</year>) <article-title>Endoplasmic reticulum is a main localization site of mTORC2</article-title>. <source>Biochemical and biophysical research communications</source> <volume>413</volume>: <fpage>46</fpage>–<lpage>52</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbrc.2011.08.034" xlink:type="simple">10.1016/j.bbrc.2011.08.034</ext-link></comment> <object-id pub-id-type="pmid">21867682</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>B</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis</article-title>. <source>Cancer research</source> <volume>70</volume>: <fpage>9360</fpage>–<lpage>9370</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/0008-5472.CAN-10-0207" xlink:type="simple">10.1158/0008-5472.CAN-10-0207</ext-link></comment> <object-id pub-id-type="pmid">20978191</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spang</surname> <given-names>A</given-names></name> (<year>2013</year>) <article-title>Retrograde traffic from the Golgi to the endoplasmic reticulum</article-title>. <source>Cold Spring Harb Perspect Biol</source> <volume>5</volume>.</mixed-citation></ref>
<ref id="pgen.1006041.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Misumi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Miki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Takatsuki</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tamura</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ikehara</surname> <given-names>Y</given-names></name> (<year>1986</year>) <article-title>Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes</article-title>. <source>The Journal of biological chemistry</source> <volume>261</volume>: <fpage>11398</fpage>–<lpage>11403</lpage>. <object-id pub-id-type="pmid">2426273</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oda</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hirose</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Takami</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Misumi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Takatsuki</surname> <given-names>A</given-names></name>, <etal>et al</etal>. (<year>1987</year>) <article-title>Brefeldin A arrests the intracellular transport of a precursor of complement C3 before its conversion site in rat hepatocytes</article-title>. <source>FEBS letters</source> <volume>214</volume>: <fpage>135</fpage>–<lpage>138</lpage>. <object-id pub-id-type="pmid">3569512</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Citterio</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Vichi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pacheco-Rodriguez</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Aponte</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Moss</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Unfolded protein response and cell death after depletion of brefeldin A-inhibited guanine nucleotide-exchange protein GBF1</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>105</volume>: <fpage>2877</fpage>–<lpage>2882</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0712224105" xlink:type="simple">10.1073/pnas.0712224105</ext-link></comment> <object-id pub-id-type="pmid">18287014</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lippincott-Schwartz</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Yuan</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Tipper</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Amherdt</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Orci</surname> <given-names>L</given-names></name>, <etal>et al</etal>. (<year>1991</year>) <article-title>Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic</article-title>. <source>Cell</source> <volume>67</volume>: <fpage>601</fpage>–<lpage>616</lpage>. <object-id pub-id-type="pmid">1682055</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Valbuena</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Guan</surname> <given-names>KL</given-names></name>, <name name-style="western"><surname>Moreno</surname> <given-names>S</given-names></name> (<year>2012</year>) <article-title>The Vam6 and Gtr1-Gtr2 pathway activates TORC1 in response to amino acids in fission yeast</article-title>. <source>J Cell Sci</source> <volume>125</volume>: <fpage>1920</fpage>–<lpage>1928</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/jcs.094219" xlink:type="simple">10.1242/jcs.094219</ext-link></comment> <object-id pub-id-type="pmid">22344254</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tatebe</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Morigasaki</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Murayama</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zeng</surname> <given-names>CT</given-names></name>, <name name-style="western"><surname>Shiozaki</surname> <given-names>K</given-names></name> (<year>2010</year>) <article-title>Rab-family GTPase regulates TOR complex 2 signaling in fission yeast</article-title>. <source>Curr Biol</source> <volume>20</volume>: <fpage>1975</fpage>–<lpage>1982</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cub.2010.10.026" xlink:type="simple">10.1016/j.cub.2010.10.026</ext-link></comment> <object-id pub-id-type="pmid">21035342</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burman</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Bourbonniere</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Philie</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Stroh</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Dejgaard</surname> <given-names>SY</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Scyl1, mutated in a recessive form of spinocerebellar neurodegeneration, regulates COPI-mediated retrograde traffic</article-title>. <source>The Journal of biological chemistry</source> <volume>283</volume>: <fpage>22774</fpage>–<lpage>22786</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M801869200" xlink:type="simple">10.1074/jbc.M801869200</ext-link></comment> <object-id pub-id-type="pmid">18556652</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Turi</surname> <given-names>TG</given-names></name>, <name name-style="western"><surname>Webster</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Rose</surname> <given-names>JK</given-names></name> (<year>1994</year>) <article-title>Brefeldin A sensitivity and resistance in Schizosaccharomyces pombe. Isolation of multiple genes conferring resistance</article-title>. <source>The Journal of biological chemistry</source> <volume>269</volume>: <fpage>24229</fpage>–<lpage>24236</lpage>. <object-id pub-id-type="pmid">7929079</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thoreen</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1</article-title>. <source>The Journal of biological chemistry</source> <volume>284</volume>: <fpage>8023</fpage>–<lpage>8032</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M900301200" xlink:type="simple">10.1074/jbc.M900301200</ext-link></comment> <object-id pub-id-type="pmid">19150980</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kinoshita</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kinoshita-Kikuta</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Takiyama</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Koike</surname> <given-names>T</given-names></name> (<year>2006</year>) <article-title>Phosphate-binding tag, a new tool to visualize phosphorylated proteins</article-title>. <source>Mol Cell Proteomics</source> <volume>5</volume>: <fpage>749</fpage>–<lpage>757</lpage>. <object-id pub-id-type="pmid">16340016</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Du</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Halova</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Kirkham</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Atkin</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>J</given-names></name> (<year>2012</year>) <article-title>TORC2 and the AGC kinase Gad8 regulate phosphorylation of the ribosomal protein S6 in fission yeast</article-title>. <source>Biology open</source> <volume>1</volume>: <fpage>884</fpage>–<lpage>888</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/bio.20122022" xlink:type="simple">10.1242/bio.20122022</ext-link></comment> <object-id pub-id-type="pmid">23213482</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matsuo</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kubo</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yamamoto</surname> <given-names>M</given-names></name> (<year>2003</year>) <article-title>Schizosaccharomyces pombe AGC family kinase Gad8p forms a conserved signaling module with TOR and PDK1-like kinases</article-title>. <source>The EMBO journal</source> <volume>22</volume>: <fpage>3073</fpage>–<lpage>3083</lpage>. <object-id pub-id-type="pmid">12805221</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawai</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nakashima</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ueno</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ushimaru</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Aiba</surname> <given-names>K</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Fission yeast tor1 functions in response to various stresses including nitrogen starvation, high osmolarity, and high temperature</article-title>. <source>Current genetics</source> <volume>39</volume>: <fpage>166</fpage>–<lpage>174</lpage>. <object-id pub-id-type="pmid">11409178</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weisman</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Choder</surname> <given-names>M</given-names></name> (<year>2001</year>) <article-title>The fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serine</article-title>. <source>The Journal of biological chemistry</source> <volume>276</volume>: <fpage>7027</fpage>–<lpage>7032</lpage>. <object-id pub-id-type="pmid">11096119</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hartmuth</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>J</given-names></name> (<year>2009</year>) <article-title>Fission yeast Tor1 functions as part of TORC1 to control mitotic entry through the stress MAPK pathway following nutrient stress</article-title>. <source>Journal of cell science</source> <volume>122</volume>: <fpage>1737</fpage>–<lpage>1746</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/jcs.049387" xlink:type="simple">10.1242/jcs.049387</ext-link></comment> <object-id pub-id-type="pmid">19417002</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Addinall</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Holstein</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Lawless</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chapman</surname> <given-names>K</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Quantitative fitness analysis shows that NMD proteins and many other protein complexes suppress or enhance distinct telomere cap defects</article-title>. <source>PLoS Genet</source> <volume>7</volume>: <fpage>e1001362</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1001362" xlink:type="simple">10.1371/journal.pgen.1001362</ext-link></comment> <object-id pub-id-type="pmid">21490951</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonifacino</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Lippincott-Schwartz</surname> <given-names>J</given-names></name> (<year>2003</year>) <article-title>Coat proteins: shaping membrane transport</article-title>. <source>Nat Rev Mol Cell Biol</source> <volume>4</volume>: <fpage>409</fpage>–<lpage>414</lpage>. <object-id pub-id-type="pmid">12728274</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Goldberg</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Orci</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Schekman</surname> <given-names>R</given-names></name> (<year>2004</year>) <article-title>Bi-directional protein transport between the ER and Golgi</article-title>. <source>Annu Rev Cell Dev Biol</source> <volume>20</volume>: <fpage>87</fpage>–<lpage>123</lpage>. <object-id pub-id-type="pmid">15473836</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bimbo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Jia</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Poh</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Karuturi</surname> <given-names>RK</given-names></name>, <name name-style="western"><surname>den Elzen</surname> <given-names>N</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Systematic deletion analysis of fission yeast protein kinases</article-title>. <source>Eukaryot Cell</source> <volume>4</volume>: <fpage>799</fpage>–<lpage>813</lpage>. <object-id pub-id-type="pmid">15821139</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burman</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Hamlin</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>McPherson</surname> <given-names>PS</given-names></name> (<year>2010</year>) <article-title>Scyl1 regulates Golgi morphology</article-title>. <source>PLoS One</source> <volume>5</volume>: <fpage>e9537</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0009537" xlink:type="simple">10.1371/journal.pone.0009537</ext-link></comment> <object-id pub-id-type="pmid">20209057</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hamlin</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Schroeder</surname> <given-names>LK</given-names></name>, <name name-style="western"><surname>Fotouhi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Dokainish</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ioannou</surname> <given-names>MS</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Scyl1 scaffolds class II Arfs to specific subcomplexes of coatomer through the gamma-COP appendage domain</article-title>. <source>Journal of cell science</source> <volume>127</volume>: <fpage>1454</fpage>–<lpage>1463</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/jcs.136481" xlink:type="simple">10.1242/jcs.136481</ext-link></comment> <object-id pub-id-type="pmid">24481816</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Yuan</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Inoki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Goraksha-Hicks</surname> <given-names>P</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Regulation of mTORC1 by the Rab and Arf GTPases</article-title>. <source>The Journal of biological chemistry</source> <volume>285</volume>: <fpage>19705</fpage>–<lpage>19709</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.C110.102483" xlink:type="simple">10.1074/jbc.C110.102483</ext-link></comment> <object-id pub-id-type="pmid">20457610</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weisman</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Choder</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Koltin</surname> <given-names>Y</given-names></name> (<year>1997</year>) <article-title>Rapamycin specifically interferes with the developmental response of fission yeast to starvation</article-title>. <source>Journal of bacteriology</source> <volume>179</volume>: <fpage>6325</fpage>–<lpage>6334</lpage>. <object-id pub-id-type="pmid">9335279</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Halova</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Du</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Kirkham</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>J</given-names></name> (<year>2013</year>) <article-title>Phosphorylation of the TOR ATP binding domain by AGC kinase constitutes a novel mode of TOR inhibition</article-title>. <source>The Journal of cell biology</source> <volume>203</volume>: <fpage>595</fpage>–<lpage>604</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1083/jcb.201305103" xlink:type="simple">10.1083/jcb.201305103</ext-link></comment> <object-id pub-id-type="pmid">24247430</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Conner</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Schmid</surname> <given-names>SL</given-names></name> (<year>2005</year>) <article-title>CVAK104 is a novel poly-L-lysine-stimulated kinase that targets the beta2-subunit of AP2</article-title>. <source>The Journal of biological chemistry</source> <volume>280</volume>: <fpage>21539</fpage>–<lpage>21544</lpage>. <object-id pub-id-type="pmid">15809293</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duwel</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ungewickell</surname> <given-names>EJ</given-names></name> (<year>2006</year>) <article-title>Clathrin-dependent association of CVAK104 with endosomes and the trans-Golgi network</article-title>. <source>Molecular biology of the cell</source> <volume>17</volume>: <fpage>4513</fpage>–<lpage>4525</lpage>. <object-id pub-id-type="pmid">16914521</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vida</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Emr</surname> <given-names>SD</given-names></name> (<year>1995</year>) <article-title>A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast</article-title>. <source>The Journal of cell biology</source> <volume>128</volume>: <fpage>779</fpage>–<lpage>792</lpage>. <object-id pub-id-type="pmid">7533169</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref043"><label>43</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Egel</surname> <given-names>R</given-names></name> (<year>1989</year>) <source>Mating-type genes, meiosis, and sporulation</source>.; <name name-style="western"><surname>Nasim</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Young</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>BF</given-names></name>, editors. <publisher-loc>San Diego</publisher-loc>: <publisher-name>Academic Press</publisher-name>.</mixed-citation></ref>
<ref id="pgen.1006041.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nielsen</surname> <given-names>O</given-names></name> (<year>1993</year>) <article-title>Signal transduction during mating and meiosis in S. pombe</article-title>. <source>Trends in cell biology</source> <volume>3</volume>: <fpage>60</fpage>–<lpage>65</lpage>. <object-id pub-id-type="pmid">14731730</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kohda</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Tanaka</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Konomi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sato</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Osumi</surname> <given-names>M</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Fission yeast autophagy induced by nitrogen starvation generates a nitrogen source that drives adaptation processes</article-title>. <source>Genes Cells</source> <volume>12</volume>: <fpage>155</fpage>–<lpage>170</lpage>. <object-id pub-id-type="pmid">17295836</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Uritani</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hidaka</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hotta</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ueno</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ushimaru</surname> <given-names>T</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Fission yeast Tor2 links nitrogen signals to cell proliferation and acts downstream of the Rheb GTPase</article-title>. <source>Genes Cells</source> <volume>11</volume>: <fpage>1367</fpage>–<lpage>1379</lpage>. <object-id pub-id-type="pmid">17121544</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shinozaki-Yabana</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yamamoto</surname> <given-names>M</given-names></name> (<year>2000</year>) <article-title>Novel WD-repeat protein Mip1p facilitates function of the meiotic regulator Mei2p in fission yeast</article-title>. <source>Mol Cell Biol</source> <volume>20</volume>: <fpage>1234</fpage>–<lpage>1242</lpage>. <object-id pub-id-type="pmid">10648609</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Willer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kjaerulff</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Davey</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nielsen</surname> <given-names>O</given-names></name> (<year>1994</year>) <article-title>Assessment of pheromone production and response in fission yeast by a halo test of induced sporulation</article-title>. <source>Yeast</source> <volume>10</volume>: <fpage>1347</fpage>–<lpage>1354</lpage>. <object-id pub-id-type="pmid">7900424</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Koch</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Krug</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Pengelley</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Macek</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hauf</surname> <given-names>S</given-names></name> (<year>2011</year>) <article-title>Mitotic substrates of the kinase aurora with roles in chromatin regulation identified through quantitative phosphoproteomics of fission yeast</article-title>. <source>Science signaling</source> <volume>4</volume>: rs6.</mixed-citation></ref>
<ref id="pgen.1006041.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carpy</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Krug</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Graf</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Koch</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Popic</surname> <given-names>S</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Absolute proteome and phosphoproteome dynamics during the cell cycle of Schizosaccharomyces pombe (Fission Yeast)</article-title>. <source>Molecular &amp; cellular proteomics: MCP</source> <volume>13</volume>: <fpage>1925</fpage>–<lpage>1936</lpage>.</mixed-citation></ref>
<ref id="pgen.1006041.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wilson-Grady</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Villen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gygi</surname> <given-names>SP</given-names></name> (<year>2008</year>) <article-title>Phosphoproteome analysis of fission yeast</article-title>. <source>Journal of proteome research</source> <volume>7</volume>: <fpage>1088</fpage>–<lpage>1097</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1021/pr7006335" xlink:type="simple">10.1021/pr7006335</ext-link></comment> <object-id pub-id-type="pmid">18257517</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maundrell</surname> <given-names>K</given-names></name> (<year>1990</year>) <article-title>nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine</article-title>. <source>The Journal of biological chemistry</source> <volume>265</volume>: <fpage>10857</fpage>–<lpage>10864</lpage>. <object-id pub-id-type="pmid">2358444</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ma</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Goldberg</surname> <given-names>J</given-names></name> (<year>2013</year>) <article-title>Rules for the recognition of dilysine retrieval motifs by coatomer</article-title>. <source>EMBO J</source> <volume>32</volume>: <fpage>926</fpage>–<lpage>937</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/emboj.2013.41" xlink:type="simple">10.1038/emboj.2013.41</ext-link></comment> <object-id pub-id-type="pmid">23481256</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>SQ</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>D</given-names></name> (<year>2013</year>) <article-title>Dietary restriction depends on nutrient composition to extend chronological lifespan in budding yeast Saccharomyces cerevisiae</article-title>. <source>PLoS One</source> <volume>8</volume>: <fpage>e64448</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0064448" xlink:type="simple">10.1371/journal.pone.0064448</ext-link></comment> <object-id pub-id-type="pmid">23691220</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bar-Peled</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Sabatini</surname> <given-names>DM</given-names></name> (<year>2014</year>) <article-title>Regulation of mTORC1 by amino acids</article-title>. <source>Trends in cell biology</source> <volume>24</volume>: <fpage>400</fpage>–<lpage>406</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tcb.2014.03.003" xlink:type="simple">10.1016/j.tcb.2014.03.003</ext-link></comment> <object-id pub-id-type="pmid">24698685</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Oliferenko</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Balasubramanian</surname> <given-names>MK</given-names></name> (<year>2002</year>) <article-title>The localization of the integral membrane protein Cps1p to the cell division site is dependent on the actomyosin ring and the septation-inducing network in Schizosaccharomyces pombe</article-title>. <source>Mol Biol Cell</source> <volume>13</volume>: <fpage>989</fpage>–<lpage>1000</lpage>. <object-id pub-id-type="pmid">11907277</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matsuyama</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Arai</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Yashiroda</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Shirai</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kamata</surname> <given-names>A</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>ORFeome cloning and global analysis of protein localization in the fission yeast Schizosaccharomyces pombe</article-title>. <source>Nat Biotechnol</source> <volume>24</volume>: <fpage>841</fpage>–<lpage>847</lpage>. <object-id pub-id-type="pmid">16823372</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yadav</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Burgos</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Parker</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>Iadevaia</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Proud</surname> <given-names>CG</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>mTOR direct interactions with Rheb-GTPase and raptor: sub-cellular localization using fluorescence lifetime imaging</article-title>. <source>BMC cell biology</source> <volume>14</volume>: <fpage>3</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2121-14-3" xlink:type="simple">10.1186/1471-2121-14-3</ext-link></comment> <object-id pub-id-type="pmid">23311891</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moreno</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Klar</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Nurse</surname> <given-names>P</given-names></name> (<year>1991</year>) <article-title>Molecular genetic analysis of fission yeast Schizosaccharomyces pombe</article-title>. <source>Methods in enzymology</source> <volume>194</volume>: <fpage>795</fpage>–<lpage>823</lpage>. <object-id pub-id-type="pmid">2005825</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Munz</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Leupold</surname> <given-names>U</given-names></name> (<year>1970</year>) <article-title>Characterization of ICR-170-induced mutations in Schizosaccharomyces pombe</article-title>. <source>Mutat Res</source> <volume>9</volume>: <fpage>199</fpage>–<lpage>212</lpage>. <object-id pub-id-type="pmid">5413678</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Petersen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Weilguny</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Egel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Nielsen</surname> <given-names>O</given-names></name> (<year>1995</year>) <article-title>Characterization of fus1 of Schizosaccharomyces pombe: a developmentally controlled function needed for conjugation</article-title>. <source>Mol Cell Biol</source> <volume>15</volume>: <fpage>3697</fpage>–<lpage>3707</lpage>. <object-id pub-id-type="pmid">7791776</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Caspari</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Dahlen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kanter-Smoler</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Lindsay</surname> <given-names>HD</given-names></name>, <name name-style="western"><surname>Hofmann</surname> <given-names>K</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Characterization of Schizosaccharomyces pombe Hus1: a PCNA-related protein that associates with Rad1 and Rad9</article-title>. <source>Molecular and cellular biology</source> <volume>20</volume>: <fpage>1254</fpage>–<lpage>1262</lpage>. <object-id pub-id-type="pmid">10648611</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kowalczyk</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Hartmuth</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Perera</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Stansfield</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>J</given-names></name> (<year>2013</year>) <article-title>Control of Sty1 MAPK activity through stabilisation of the Pyp2 MAPK phosphatase</article-title>. <source>J Cell Sci</source> <volume>126</volume>: <fpage>3324</fpage>–<lpage>3332</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/jcs.122531" xlink:type="simple">10.1242/jcs.122531</ext-link></comment> <object-id pub-id-type="pmid">23690545</object-id></mixed-citation></ref>
<ref id="pgen.1006041.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ikeda</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Morigasaki</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tatebe</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Tamanoi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Shiozaki</surname> <given-names>K</given-names></name> (<year>2008</year>) <article-title>Fission yeast TOR complex 2 activates the AGC-family Gad8 kinase essential for stress resistance and cell cycle control</article-title>. <source>Cell Cycle</source> <volume>7</volume>: <fpage>358</fpage>–<lpage>364</lpage>. <object-id pub-id-type="pmid">18235227</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>